Heart Disease Trial, Recruiting (NCT04779008)

Heart Disease Trial, Recruiting NCT04779008 Sponsor: Henan Institute of Cardiovascular Epidemiology Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT04779008 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have three blocked heart arteries and have been scheduled for coronary artery bypass graft (CABG) heart surgery

Who may not be able to join:

People whose bodies cannot tolerate the remote ischemic preconditioning (RIPC) procedure used in this trial (confirm with trial site)
People who have blood vessel disease affecting their arms
People who have had a heart attack complicated by a condition where the heart cannot pump enough blood, within the last 30 days
People whose situation is a medical emergency
People who have serious heart structural problems or serious irregular heart rhythms
People who have severe high blood pressure that is not controlled, specifically with a top number at or above 180 mmHg or a bottom number at or above 120 mmHg
People who have serious liver, kidney, or lung disease
People who have a mental health condition that would prevent them from cooperating with the study
People who are unable to give their informed consent to participate
People who are currently taking the medications glibenclamide or nicorandil, as these may interfere with the trial procedure
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Muwei Li, Ph.D, Fuwai central China cardiovascular hospotial

Phone: +8615670510031

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04779008

Sponsor: Henan Institute of Cardiovascular Epidemiology

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: +8615670510031

More information: https://clinicaltrials.gov/study/NCT04779008

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have three blocked heart arteries and have been scheduled for coronary artery bypass graft (CABG) heart surgery

Who may not be able to join:

People whose bodies cannot tolerate the remote ischemic preconditioning (RIPC) procedure used in this trial (confirm with trial site)
People who have blood vessel disease affecting their arms
People who have had a heart attack complicated by a condition where the heart cannot pump enough blood, within the last 30 days
People whose situation is a medical emergency
People who have serious heart structural problems or serious irregular heart rhythms
People who have severe high blood pressure that is not controlled, specifically with a top number at or above 180 mmHg or a bottom number at or above 120 mmHg
People who have serious liver, kidney, or lung disease
People who have a mental health condition that would prevent them from cooperating with the study
People who are unable to give their informed consent to participate
People who are currently taking the medications glibenclamide or nicorandil, as these may interfere with the trial procedure
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Henan Institute of Cardiovascular Epidemiology

Registry

ClinicalTrials.gov

Start date

10 March 2021

Est. completion

1 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change of MBF by SPECT; Change of MPR by SPECT; Change of MBF by CE; Change of MPR by CE

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov